Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Replacement of Fhit in cancer cells suppresses tumorigenicity.

Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, Sard L, Tagliabue E, Greco A, Fusetti L, Schwartz G, Pierotti MA, Croce CM, Huebner K.

Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13771-6.

2.

Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.

Barnes LD, Garrison PN, Siprashvili Z, Guranowski A, Robinson AK, Ingram SW, Croce CM, Ohta M, Huebner K.

Biochemistry. 1996 Sep 10;35(36):11529-35.

PMID:
8794732
3.

Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.

Werner NS, Siprashvili Z, Fong LY, Marquitan G, Schröder JK, Bardenheuer W, Seeber S, Huebner K, Schütte J, Opalka B.

Cancer Res. 2000 Jun 1;60(11):2780-5.

4.
5.

How many tumor suppressor genes are involved in human lung carcinogenesis?

Kohno T, Yokota J.

Carcinogenesis. 1999 Aug;20(8):1403-10. Review.

PMID:
10426784
6.
7.

[Analysis of suppressive roles of BLU gene at 3p21.3 in nasopharyngeal carcinoma].

Liu XQ, Pan ZG, Li MZ, Jiang JH, Fu J, Long QX, Wang XZ, Zeng YX.

Ai Zheng. 2003 Feb;22(2):128-35. Chinese.

PMID:
12600284
8.

Fragile histidine triad gene and skin cancer.

Zanesi N, Croce CM.

Eur J Dermatol. 2001 Sep-Oct;11(5):401-4. Review.

PMID:
11525944
9.

Inactivation of the FHIT gene favors bladder cancer development.

Vecchione A, Sevignani C, Giarnieri E, Zanesi N, Ishii H, Cesari R, Fong LY, Gomella LG, Croce CM, Baffa R.

Clin Cancer Res. 2004 Nov 15;10(22):7607-12.

10.

Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma.

Fang JM, Arlt MF, Burgess AC, Dagenais SL, Beer DG, Glover TW.

Genes Chromosomes Cancer. 2001 Mar;30(3):292-8.

11.

Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene.

Zimonjic DB, Druck T, Ohta M, Kastury K, Croce CM, Popescu NC, Huebner K.

Cancer Res. 1997 Mar 15;57(6):1166-70.

12.

The role of deletions at the FRA3B/FHIT locus in carcinogenesis.

Huebner K, Druck T, Siprashvili Z, Croce CM, Kovatich A, McCue PA.

Recent Results Cancer Res. 1998;154:200-15.

PMID:
10027001
13.

The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers.

Turner BC, Ottey M, Zimonjic DB, Potoczek M, Hauck WW, Pequignot E, Keck-Waggoner CL, Sevignani C, Aldaz CM, McCue PA, Palazzo J, Huebner K, Popescu NC.

Cancer Res. 2002 Jul 15;62(14):4054-60.

14.

FHITness and cancer.

Druck T, Berk L, Huebner K.

Oncol Res. 1998;10(7):341-5. Review.

PMID:
10063967
15.

Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.

Pavelić K, Krizanac S, Cacev T, Hadzija MP, Radosević S, Crnić I, Levanat S, Kapitanović S.

Mol Med. 2001 Jul;7(7):442-53.

16.

Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.

Ahmadian M, Wistuba II, Fong KM, Behrens C, Kodagoda DR, Saboorian MH, Shay J, Tomlinson GE, Blum J, Minna JD, Gazdar AF.

Cancer Res. 1997 Sep 1;57(17):3664-8.

17.

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.

Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K.

Cell. 1996 Feb 23;84(4):587-97.

18.

Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.

Ishii H, Dumon KR, Vecchione A, Trapasso F, Mimori K, Alder H, Mori M, Sozzi G, Baffa R, Huebner K, Croce CM.

Cancer Res. 2001 Feb 15;61(4):1578-84.

19.

Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.

Pavelić K, Dedivitis RA, Kapitanović S, Cacev T, Guirado CR, Danić D, Radosević S, Brkić K, Pegan B, Krizanac S, Kusić Z, Spaventi S, Bura M.

Mutat Res. 2006 Jul 25;599(1-2):45-57. Epub 2006 May 15.

PMID:
16698048
20.

Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.

Ishii H, Vecchione A, Furukawa Y, Sutheesophon K, Han SY, Druck T, Kuroki T, Trapasso F, Nishimura M, Saito Y, Ozawa K, Croce CM, Huebner K, Furukawa Y.

Mol Cancer Res. 2003 Nov;1(13):940-7.

Supplemental Content

Support Center